Weil lawyer invested millions in fund that owned Pegasus spyware maker

Financial TimesFriday, October 31, 2025 at 5:00:06 AM
Weil lawyer invested millions in fund that owned Pegasus spyware maker
Gerhard Schmidt, a lawyer at Weil, has come under scrutiny for investing millions into a private equity fund that acquired NSO Group, the maker of the controversial Pegasus spyware. This raises significant ethical concerns, as Schmidt not only financially supported the fund but also served on the board overseeing NSO. The implications of this investment are profound, given the global outcry over the misuse of Pegasus for surveillance and privacy violations.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Kuwait’s Pension Fund Giant Eyes Return to Private Equity Bets
PositiveFinancial Markets
Kuwait's pension fund is making a significant move by returning to private equity investments after a break, which could inject billions into an industry currently facing fundraising challenges. This decision is crucial as it not only revitalizes the fund's investment strategy but also provides much-needed capital to private equity firms, potentially boosting economic growth and innovation.
How Private Equity Investors Read Founders Before The Market Does
PositiveFinancial Markets
In the world of private equity, understanding how investors perceive founders before the market catches on can be a game changer for Chief Marketing Officers (CMOs). This insight reveals the metrics and patterns that private equity investors prioritize, which go beyond traditional financial spreadsheets. By grasping these nuances, CMOs can better align their strategies with investor expectations, ultimately enhancing the value of the organizations they help build.
Democratic Lawmakers Push Back on Adding Private Equity to the 401(k) Menu
NegativeFinancial Markets
Democratic lawmakers, including prominent figures like Elizabeth Warren and Bernie Sanders, are raising concerns about the potential risks of allowing private equity investments in 401(k) retirement plans. In a recent letter to regulators, they argue that such moves could jeopardize the savings of everyday Americans, highlighting the need for caution in financial regulations. This matters because it touches on the security of retirement funds for millions, emphasizing the ongoing debate about how to best protect investors.
Exclusive-Saudi Arabia plans to refocus $925 billion fund after gigaproject delays, source says
NeutralFinancial Markets
Saudi Arabia is reportedly planning to refocus its $925 billion fund due to delays in its gigaprojects. This shift in strategy is significant as it reflects the kingdom's response to challenges in its ambitious development plans, which are crucial for diversifying its economy away from oil dependency. The adjustments could lead to new investment opportunities and a reevaluation of priorities within the fund.
Warren, Sanders Say PE in 401(K)s Is ‘Dangerous’ for Americans
NegativeFinancial Markets
Senators Elizabeth Warren and Bernie Sanders have raised alarms about President Trump's decision to allow private equity and cryptocurrency to play a larger role in 401(k) retirement plans. They argue that this shift could jeopardize the financial security of millions of Americans, potentially exposing them to higher risks and losses. This matters because retirement savings are crucial for individuals' futures, and any changes that could undermine these savings warrant serious scrutiny.
Latest from Financial Markets
AbbVie lifts annual profit forecast on resilient demand for newer immunology drugs
PositiveFinancial Markets
AbbVie has raised its annual profit forecast, reflecting strong demand for its newer immunology drugs. This is significant as it highlights the company's ability to adapt and thrive in a competitive market, reassuring investors about its growth potential and the effectiveness of its innovative treatments.
AbbVie lifts full-year profit outlook amid strong psoriasis drug demand
PositiveFinancial Markets
AbbVie has raised its full-year profit outlook, driven by strong demand for its psoriasis drug. This positive news reflects the company's robust performance in the pharmaceutical market, highlighting the effectiveness of its treatments and the growing need for solutions in dermatology. Investors and stakeholders are likely to view this as a sign of AbbVie's continued growth and innovation in addressing chronic conditions.
Goldman Sachs CEO: AI’s opportunity is enormous, but ‘there will be winners and losers’
PositiveFinancial Markets
Goldman Sachs CEO David Solomon highlights the immense potential of artificial intelligence as a driving force for U.S. economic growth. However, he cautions that the journey will not be straightforward, indicating that while some will thrive, others may struggle. This insight is crucial as businesses and investors navigate the evolving landscape of AI, making strategic decisions that could determine their success in the future.
Twilio stock maintains Buy rating at Rosenblatt after record revenue
PositiveFinancial Markets
Twilio's stock has received a Buy rating from Rosenblatt following the company's record revenue performance. This positive outlook reflects investor confidence in Twilio's growth potential and its ability to capitalize on increasing demand for communication solutions. As businesses continue to prioritize digital transformation, Twilio's strong financial results position it well for future success.
KB Financial earnings missed, revenue fell short of estimates
NegativeFinancial Markets
KB Financial reported disappointing earnings, with revenue falling short of analysts' estimates. This news is significant as it reflects the company's struggles in a challenging economic environment, potentially impacting investor confidence and future growth prospects.
Marcus Corporation shares edge up as earnings beat offsets narrow revenue miss
PositiveFinancial Markets
Marcus Corporation's shares have seen a slight increase following their latest earnings report, which surpassed expectations despite a small revenue miss. This is significant as it reflects the company's ability to manage costs and drive profitability, which can instill confidence in investors and potentially lead to further growth.